Epilepsy Monitoring Device Market Size - By Product, By End Use, Forecast, 2025 - 2034

Epilepsy Monitoring Device Market Size

The global epilepsy monitoring device market size was valued at USD 632.5 million in 2024. The market is expected to reach from USD 662 million in 2025 to USD 1.04 billion in 2034, growing at a CAGR of 5.2% during the forecast period. Healthcare professionals use tools such as epilepsy monitoring devices in people that experience seizures due to epilepsy. These devices track the brain activity and benefit them to identify unusual electrical patterns in the brain, which are linked to epilepsy. Doctors can better understand each patient's condition and determine the most effective treatment method by using these tools.
 

The growth of the global epilepsy monitoring device market is highly attributed due to the increasing prevalence of epilepsy, which is a key catalyst that is accelerating the market growth. For instance, according to the data from the World Health Organization (WHO), in 2024, around 50 million people globally were affected. Moreover, WHO also reported that around 5 million new epilepsy diagnoses are made annually.
 

Thus, these conditions require long term monitoring and epilepsy treatment drugs, which was valued at around USD 8.6 billion in 2024, and management. Epilepsy monitoring devices play a significant role in accurately detecting abnormal brain activity and seizure classification. Therefore, as the prevalence of epilepsy conditions increases, so does the demand for these devices, which in turn necessities the need for epilepsy monitoring devices in order to ensure the safety and effective treatment, thereby fostering market growth.
 

Additionally, rapid technical improvements are fundamentally responsible for the market's strong growth in epilepsy monitoring devices. The precision, usability, and effectiveness of epilepsy diagnosis and treatment are being greatly improved by innovations including wearable and wireless EEG equipment, AI-powered diagnostic tools, and real-time remote monitoring systems. In addition to enhancing patient outcomes, these developments are increasing the devices' use in homecare, ambulatory, and hospital settings. Thus, these technological innovations are significantly contributing to the acceleration of industry growth.
 

Epilepsy Monitoring Device Market Trends

• Technological advancements in epilepsy monitoring devices are one of the major accelerators for the growth of the market.
   
• For instance, Empatica's EpiMonitor, is a key accelerator for market growth, EpiMonitor is an FDA-cleared epilepsy monitoring system launched in February 2024 designed for adults and children aged 6 years and above. EpiMonitor utilizes Empatica’s advanced EmbracePlus medical watch, coupled with a companion smartphone application and intelligent algorithms, to detect generalized tonic-clonic seizures with a reported 98% accuracy rate and a low false alarm rate.
   
• Moreover, in December 2023, Empatica declared a groundbreaking study aimed at developing a seizure forecasting algorithm, based on the largest real-world dataset of epilepsy patient monitoring.
   
• This study marks a critical step forward in predictive neurology, where machine learning and artificial intelligence are utilized to predict seizures before they occur, potentially changing the way in which epilepsy is overseen and treated.
   
• Together, these trends are creating strong, sustained demand across multiple sectors, thereby fostering market growth in the forward direction.
   

Trump Administration Tariffs

• Tariffs on Chinese imports, including essential components such as stainless-steel parts, control panels, and sensors many of which are crucial for epilepsy monitoring device are anticipated to raise production costs across the global market.
   
• A significant number of manufacturers currently depend on China for cost-efficient sourcing of these critical parts. With the imposition of tariffs, supply chains could be disrupted, resulting in elevated manufacturing expenses.
   
• Therefore, companies in the epilepsy monitoring device market are expected to reassess their sourcing strategies and reduce over reliance on Chinese imports. This is likely to encourage a gradual transition toward alternative procurement and manufacturing locations such as India, Vietnam, Mexico, and Eastern European countries, where trade risks are comparatively lower and operational costs remain favourable.
   
• However, in the near term, these strategic shifts may lead to challenges such as project delays and added expenses during vendor onboarding.
   

Epilepsy Monitoring Device Market Analysis

Based on product, the epilepsy monitoring device market is segmented into wearable devices and conventional devices. The conventional devices segment is bifurcated into deep brain stimulation devices and monitoring devices. Further, the monitoring device segment is sub-segmented into EEG device, EMG device, MEG device, and other monitoring devices. The conventional devices segment dominated the market with the largest revenue of USD 383.3 million in 2024 and is expected to grow at a significant CAGR over the forecast period.
 

• The growth of the segment is highly attributed due to the widespread clinical applicability, technological refinement, and higher diagnostic accuracy compared to other product types.
   
• The ongoing advancement in the epilepsy monitoring devices and improvement in the device features such as real time monitoring capabilities, cloud integration, and AI integration are further fostering the adoption of these advanced epilepsy monitoring devices in the pharmaceutical sectors.
   
• Moreover, EEG devices proceed to be the foundation of epilepsy diagnosis and seizure classification, due to their non-invasive nature and ability to convey real-time brainwave analysis, thereby quickening the demand for advanced epilepsy monitoring devices, further reinforcing the development of the segment within the fast-pacing market.

Based on end use, the epilepsy monitoring device market is segmented into hospitals and clinics, biotechnology, ambulatory surgical centers, neurology centers, diagnostic centers, and home care settings. The hospitals and clinics segment are anticipated to reach USD 480 million by 2034.
 

• Hospitals and clinics are well-equipped to provide continuous, high-level care, which makes them an important setting for managing epilepsy. These facilities typically have the tools and infrastructure needed to support the use of specialized monitoring equipment. This includes things such as electronic health records, neuroimaging machines, ICU setups, and departments focused on neurological care.
   
• With this setup, hospitals can effectively use devices such as video EEGs, MEGs, and systems for continuous brain monitoring to quickly detect seizure activity and respond as needed.
   
• In addition, hospitals have access to experienced professionals such as neurologists, neurophysiologists, and critical care staff that are trained to handle different types of epilepsy cases.
   
• These teams often work together across specialties, which makes it easier to monitor patients. This collaborative care model makes hospitals ideal for comprehensive epilepsy treatment.

The U.S. epilepsy monitoring device market is projected to grow significantly, reaching USD 403.7 million by 2034.
 

• The growing prevalence of the epilepsy in the U.S. in the key catalyst for the growth of the market in the U.S.
   
• For instance, as per the data from the Centers for Disease Control and Prevention (CDC) in 2024, around 3 million adults have epilepsy in the U.S.
   
• Thus, this rising burden of the epilepsy is propelling the market in the U.S. as many manufacturers and research institutes are undertaking various research to develop advanced devices and user-friendly solution to combat the condition, thereby propelling the market growth in the country.  
   

Europe: The epilepsy monitoring device market in UK is expected to experience significant and promising growth from 2025 to 2034.
 

• Healthcare technology advancement is greatly aided by the UK's extensive and vibrant medical device R&D ecosystem. Data from the UK Parliament indicates that in 2022, the nation made large investments in R&D, with a notable portion of those investments going to the medical device industry. The development and marketing of cutting-edge medical innovations, such as epilepsy monitoring equipment, are aided by this financing.
   
• Improved diagnostic precision, quicker product development cycles, and the incorporation of digital health technologies are all made possible by the emphasis on research and development.
   
• Further, the robust research and development environment keeps propelling the expansion and use of epilepsy monitoring devices throughout the UK.
   
• Additionally, as reported by epilepsy action in 2023, an estimated 633,000 people are living with epilepsy in the UK, which in turn fuels the demand for epilepsy monitoring devices.
   

Asia Pacific: The epilepsy monitoring device market in the Japan is projected to grow significantly from 2025 to 2034.
 

• Japan has one of the fastest aging populations globally. For instance, as per estimates, Japan has around 36.25 million people aged 65 years and above, which leads to one-third of the entire Japanese population. The individuals of this demographic are highly prone to age related neurological conditions, including epilepsy, stroke, and neurodegenerative disorders, increasing the demand for advanced monitoring devices.
   
• Devices such as wearable EEGs, video EEG systems, and continuous monitoring tools are becoming critical for capturing real-time brain activity, minimizing hospital visits, and improving treatment outcomes.
   

Middle East and Africa: The Saudi Arabia epilepsy monitoring device market is projected to grow significantly from 2025 to 2034.
 

• Saudi Arabia’s Vision 2030 puts a strong focus on improving healthcare and boosting medical technology production as part of its plan to diversify the economy.
   
• To support this, both the government and private sector are investing heavily in developing facilities to improve healthcare infrastructure, with a particular focus on neurological care and digital health solutions.
   
• This has led to the adoption of advanced epilepsy monitoring devices, such as wearable EEGs, ambulatory monitoring systems, and real-time seizure detection tools, which are essential for early diagnosis, remote monitoring, and continuous patient management, propelling the market growth in the country.
   

Epilepsy Monitoring Device Market Share

The market is highly fragmented with key players and new entrants constantly working to offer new products. In terms of revenue, the market share lies with the top 5 players which comprise Boston Scientific Corporation, Koninklijke Philips, Medtronic, Masimo Corporation, Cadwell Industries, accounting for approximately 40% of the total market share. Moreover, strategic collaboration with medical device manufacturers, research institutions, and regulatory bodies plays a critical role in advancing product development and ensuring regulatory approval. Increasing awareness is encouraging adoption across sectors and enabling market players to solidify their position in this expanding industry.
 

Epilepsy Monitoring Device Market Companies

Some of the eminent market participants operating in the epilepsy monitoring device industry include:

• Boston Scientific Corporation 
• Cadwell Industries
• Compumedics
• Empatica
• Koninklijke Philips
• Masimo Corporation
• Medpage
• Medtronic
• Natus Medical Incorporated
• NeuroWave Systems
• NIHON KOHDEN CORPORATION
• Seer Medical
• Stratus
• The Magstim
• Zeto
   
• Medtronic has a strong global presence, with its products being sold in more than 150 countries.
   
• Koninklijke Philips N.V. reported a total revenue of approximately USD 19.5 billion for the year 2024, reflecting its significant role in the global healthcare technology market.
   

Epilepsy Monitoring Device Industry News:

• In November 2024, Nihon Kohden, a global leader in medical device innovation, announced the acquisition of a 71.4% stake in NeuroAdvanced Corp., the parent company of Ad-Tech Medical Instrument Corporation. This strategic move combined Nihon Kohden's expertise in electroencephalography (EEG) systems with Ad-Tech's specialized intracranial electrodes, enhancing the company's ability to address complex neurological conditions, including drug-resistant epilepsy.
   
• In May 2022, Epilepsy Alarms UK announced the launch of the mjn-SERAS, a groundbreaking wearable device designed to predict epileptic seizures before they occur. This intelligent earbud utilizes advanced sensors and artificial intelligence to monitor brain activity, providing users with a 1 to 3-minute warning prior to a seizure. The device connects via Bluetooth to an Android smartphone, delivering visual and auditory alerts to both the user and their caregivers. Certified as a medical device in Europe, the mjn-SERAS represents a significant advancement in seizure prediction technology.
   

The epilepsy monitoring device market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Wearable devices
• Conventional devices
  • Deep brain stimulation devices
  • Monitoring devices
    • EEG devices
      • Standard EEG
      • Video EEG
      • Other EEG devices
    • EMG devices
    • MEG devices
    • Other monitoring devices

Market, By End Use

• Hospitals and clinics
• Ambulatory surgical centers
• Neurology centers
• Diagnostic centers
• Home care settings

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific 
  • China
  • Japan
  • India
  • Australia
• Latin America 
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa 
  • South Africa
  • Saudi Arabia
  • UAE